BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 38825453)

  • 1. Microelimination of Hepatitis C in patients with substance use and dual disorders - a Portuguese study.
    Faria I; Facão R; Murta F; Carvalho R; Silva C; Murta I; Valente C
    Jpn J Infect Dis; 2024 May; ():. PubMed ID: 38825453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hepatitis C virus infection in patients with chronic mental disorders: The relevance of dual disorders.
    Roncero C; Buch-Vicente B; Martín-Sánchez ÁM; Álvarez-Navares AI; Andrés-Olivera P; Gamonal-Limcaoco S; Lozano-López MT; Aguilar L; Sánchez-Casado F; García-Ullán L
    Gastroenterol Hepatol; 2023 Mar; 46(3):171-177. PubMed ID: 35780956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B and C prevalence in Portugal: disparity between the general population and high-risk groups.
    Carvalhana SC; Leitão J; Alves AC; Bourbon M; Cortez-Pinto H
    Eur J Gastroenterol Hepatol; 2016 Jun; 28(6):640-4. PubMed ID: 26866523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatitis C in a psychiatric setting: A forgotten reservoir?].
    Rolland B; Bailly F; Cutarella C; Drevon O; Carrieri P; Darque A; Hallouche N; Maptue N; Pol S; Llorca PM; Lang JP
    Encephale; 2021 Apr; 47(2):181-184. PubMed ID: 32473777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in inpatient and outpatient hepatitis C virus prevalence and linkage to care rates in a safety net hospital hepatitis C screening program.
    Veeramachaneni H; Park B; Blakely D; Palacio A; Darby R; Fluker SA; Lyles RH; Miller LS
    J Gastroenterol Hepatol; 2021 Aug; 36(8):2285-2291. PubMed ID: 33724551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Barriers to linkage to care in hepatitis C patients with substance use disorders and dual diagnoses, despite centralized management.
    Grau-López L; Marcos-Fosch C; Daigre C; Palma-Alvarez RF; Rando-Segura A; Llaneras J; Perea-Ortueta M; Rodriguez-Frias F; Martínez-Luna N; Riveiro-Barciela M; Ramos-Quiroga JA; Colom J; Esteban R; Buti M
    Therap Adv Gastroenterol; 2021; 14():17562848211016563. PubMed ID: 34471422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-centered and integrated outreach care for chronic hepatitis C patients with serious mental illness in Taiwan.
    Huang CF; Jang TY; Yu SC; Huang SC; Ho SL; Yeh ML; Wang CW; Liang PC; Wei YJ; Hsu PY; Huang CI; Hsieh MY; Lin YH; Yu SL; Wu PF; Chen YH; Chien SC; Huang JF; Dai CY; Chuang WL; Wang TJ; Yu ML
    Kaohsiung J Med Sci; 2024 Jan; 40(1):86-93. PubMed ID: 37942784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a strategy for identification of hepatitis C virus carriers in outpatient and emergency units: contribution to the microelimination of hepatitis C in Brazil.
    Gardona R; Appel F; Ercolin S; Carvalho-Filho RJ; Barbosa DA; Ferraz ML
    Braz J Infect Dis; 2021; 25(2):101546. PubMed ID: 33636108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of hepatitis C, hepatitis B and HIV and their therapeutic management in a French public psychiatric hospital.
    Icole F; Haghnejad V; Jeannoel C; Besançon P; Boulanger F; Bronowicki JP
    Encephale; 2024 Feb; ():. PubMed ID: 38368186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effects of pegylated interferon plus ribavirin in chronic hepatitis C patients with occult hepatitis B virus dual infection.
    Chen LW; Chien RN; Yen CL; Chang JJ; Liu CJ; Lin CL
    J Gastroenterol Hepatol; 2010 Feb; 25(2):259-63. PubMed ID: 19817959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hepatitis C epidemiology in the central area of Portugal. Prevalence of anti-HCV in the population of the district of Coimbra].
    Santos A; Carvalho A; Bento D; Sá R; Tomaz J; Rodrigues V; Pais L; Porto A
    Acta Med Port; 1993 Dec; 6(12):567-72. PubMed ID: 8165925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiology of hepatitis C in central Portugal. Prevalence of anti-HCV in the population of the Coimbra District.
    Santos A; Carvalho A; Bento D; Sá R; Tomáz J; Rodrigues V; Pais L; Porto A
    Acta Med Port; 1994 Dec; 7 Suppl 1():S3-8. PubMed ID: 7653277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease in the prevalence of hepatitis B and a low prevalence of hepatitis C virus infections in the general population of the Seychelles.
    Bovet P; Yersin C; Herminie P; Lavanchy D; Frei PC
    Bull World Health Organ; 1999; 77(11):923-8. PubMed ID: 10612888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus infection in a large cohort of homosexually active men: independent associations with HIV-1 infection and injecting drug use but not sexual behaviour.
    Bodsworth NJ; Cunningham P; Kaldor J; Donovan B
    Genitourin Med; 1996 Apr; 72(2):118-22. PubMed ID: 8698359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microelimination of Chronic Hepatitis C by Universal Screening Plus Direct-Acting Antivirals for Incarcerated Persons in Taiwan.
    Yang TH; Fang YJ; Hsu SJ; Lee JY; Chiu MC; Yu JJ; Kuo CC; Chen CH
    Open Forum Infect Dis; 2020 Aug; 7(8):ofaa301. PubMed ID: 32818142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for hepatitis C in a general adult population in a low-prevalence area: the Tromsø study.
    Kileng H; Gutteberg T; Goll R; Paulssen EJ
    BMC Infect Dis; 2019 Feb; 19(1):189. PubMed ID: 30808290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comprehensive Hepatitis B Surface Antigen-Positive Patient-Centered Screening and Linkage to Care Strategies Targeting Microelimination of Hepatitis C Virus Infection in Chongqing, China.
    Cai D; Zhang D; Hu P; Ren H
    Can J Gastroenterol Hepatol; 2022; 2022():9644576. PubMed ID: 36606100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Hepatitis C Screening and Treatment Among Psychiatry Inpatients.
    Mandel E; Biondi MJ; Mendlowitz A; Maheandiran M; Hollingdrake E; Vanderhoff A; Wolfson-Stofko B; Capraru C; Feld JJ; Logan R
    J Clin Psychiatry; 2023 Jul; 84(5):. PubMed ID: 37530609
    [No Abstract]   [Full Text] [Related]  

  • 19. A novel program for treating patients with trimorbidity: hepatitis C, serious mental illness, and active substance use.
    Sockalingam S; Blank D; Banga CA; Mason K; Dodd Z; Powis J
    Eur J Gastroenterol Hepatol; 2013 Dec; 25(12):1377-84. PubMed ID: 23680911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro.
    Edelenyi-Pinto M; Carvalho AP; Nogueira C; Ferreira Júnior O; Schechter M
    Mem Inst Oswaldo Cruz; 1993; 88(2):305-7. PubMed ID: 7509022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.